NOD1 (Q9Y239) variants and mutations
NOD1 (also known as Q9Y239) is a human protein-coding gene encoding a nucleotide-binding oligomerization domain-containing protein 1 protein. It detects bacterial peptidoglycan-derived molecules in the cytosol and activates NF-kappaB and MAPK pathways. Genetic variation can modify susceptibility to inflammatory and infectious diseases, although strong monogenic NOD1 deficiency phenotypes are uncommon. This analysis covers 1,315 NOD1 variants and mutations. Of these, 79% have computational variant effect predictions. Disease context includes adolescent idiopathic scoliosis, Abnormality of refraction, and arthropathy. Example NOD1 variants include E2A, E2K, and E3D.
Variant analysis overview
- Gene: NOD1
- Protein: Q9Y239
- UniProt accession: Q9Y239
- Organism: Homo sapiens
- Variants analyzed: 1315
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 1,154 unspecified-consequence records; 1 stop lost; 1 stop retained variant; 63 synonymous variants; 17 frameshift variants; 68 missense variants; 1 protein altering variant; 3 in-frame deletions; 4 stop-gained variants; 4 splice-region variants; 1 substitution
- Prediction scores: 1,033 variants have prediction scores (79% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: adolescent idiopathic scoliosis, Abnormality of refraction, arthropathy, gestational diabetes, neoplasm, head and neck squamous cell carcinoma, colorectal carcinoma, glioblastoma, cancer, hepatocellular carcinoma, Insulin resistance, coronary artery disorder.
Protein structure and variant hotspots
- Protein features: 2 domains; 1 binding sites.
- Structural context: 543 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable NOD1 variants
Examples include E2A, E2K, E3D, E3Q, Q4H, G5D, H6Y, S7N. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- E2A (p.Glu2Ala), ExAC rs764253327, REVEL 0.13, CADD 17.40
- E2K (p.Glu2Lys), gnomAD rs1197086439, REVEL 0.24, CADD 24.40
- E3D (p.Glu3Asp), ESP rs369740466, ExAC rs369740466, TOPMed rs369740466, gnomAD rs369740466, REVEL 0.14, CADD 2.17
- E3Q (p.Glu3Gln), NCI-TCGA Cosmic COSV5611, Variant assessed as somatic; moderate impact.
- Q4H (p.Gln4His), NCI-TCGA Cosmic COSV5611, REVEL 0.16, CADD 2.85, Variant assessed as somatic; moderate impact.
- G5D (p.Gly5Asp), NCI-TCGA TCGA novel, REVEL 0.18, CADD 1.33, Variant assessed as somatic; moderate impact.
- H6Y (p.His6Tyr), NCI-TCGA Cosmic COSV9976, Variant assessed as somatic; moderate impact.
- S7N (p.Ser7Asn), ESP rs61757653, ExAC rs61757653, TOPMed rs61757653, gnomAD rs61757653, REVEL 0.02, CADD 4.51
- M9L (p.Met9Leu), Ensembl rs1786441686, REVEL 0.15, CADD 16.50
- E10* (p.Glu10Ter), TOPMed rs1000744101, gnomAD rs1000744101
- E10K (p.Glu10Lys), TOPMed rs1000744101, gnomAD rs1000744101, REVEL 0.04, CADD 16.80
- I11V (p.Ile11Val), ESP rs375357578, ExAC rs375357578, TOPMed rs375357578, gnomAD rs375357578, REVEL 0.06, CADD 2.82
- I12N (p.Ile12Asn), TOPMed rs1562698027, REVEL 0.20, CADD 4.71
- I12T (p.Ile12Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S14L (p.Ser14Leu), Ensembl rs1562697973, REVEL 0.12, CADD 11.80
- S16F (p.Ser16Phe), rs771370435, ClinGen CA4205340, ClinVar RCV004073032, ExAC rs771370435, REVEL 0.16, CADD 14.00, Uncertain significance, not specified
- S16T (p.Ser16Thr), rs776959941, ClinGen CA4205341, ClinVar RCV004073031, ExAC rs776959941, REVEL 0.07, CADD 0.28, Uncertain significance, not specified
- H17Y (p.His17Tyr), TOPMed rs1264431689, gnomAD rs1264431689, REVEL 0.09, CADD 5.27
- P18H (p.Pro18His), ExAC rs747367948, gnomAD rs747367948, REVEL 0.15, CADD 19.80
- P18R (p.Pro18Arg), ExAC rs747367948, gnomAD rs747367948
- H19D (p.His19Asp), ExAC rs768207776, gnomAD rs768207776, REVEL 0.21, CADD 1.73
- L23V (p.Leu23Val), gnomAD rs1470576884, REVEL 0.15, CADD 11.40
- S25R (p.Ser25Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N26S (p.Asn26Ser), 1000Genomes rs181282889, ExAC rs181282889, TOPMed rs181282889, gnomAD rs181282889, REVEL 0.05, CADD 13.90
- R27L (p.Arg27Leu), ExAC rs750433986, TOPMed rs750433986, gnomAD rs750433986
- R27Q (p.Arg27Gln), rs750433986, NCI-TCGA Cosmic COSV5611, ExAC rs750433986, TOPMed rs750433986, REVEL 0.47, CADD 26.00, Variant assessed as somatic; moderate impact.
- R27W (p.Arg27Trp), ExAC rs756109491, TOPMed rs756109491, gnomAD rs756109491, REVEL 0.61, CADD 26.40
- E28K (p.Glu28Lys), Ensembl rs2128069878, REVEL 0.30, CADD 25.80
- L29F (p.Leu29Phe), TOPMed rs1786432916
- L29V (p.Leu29Val), TOPMed rs1786432916, REVEL 0.05, CADD 16.10
- L30P (p.Leu30Pro), TOPMed rs755169571, REVEL 0.83, CADD 27.10, Uncertain significance, not specified
- V31F (p.Val31Phe), gnomAD rs1341336569, REVEL 0.49, CADD 25.20
- T32I (p.Thr32Ile), TOPMed rs1786430513
- H33P (p.His33Pro), Ensembl rs1786430236, REVEL 0.26, CADD 18.70
- I34M (p.Ile34Met), TOPMed rs1786429836
- R35C (p.Arg35Cys), ExAC rs757036750, TOPMed rs757036750, gnomAD rs757036750, REVEL 0.25, CADD 26.60
- R35H (p.Arg35His), rs764315889, ClinGen CA4205329, ClinVar RCV004072552, ExAC rs764315889, REVEL 0.03, CADD 15.60, Uncertain significance, not specified
- R35L (p.Arg35Leu), ExAC rs764315889, TOPMed rs764315889, gnomAD rs764315889, REVEL 0.15, CADD 22.70, Uncertain significance
- N36H (p.Asn36His), ExAC rs763163985, gnomAD rs763163985, REVEL 0.12, CADD 20.80
- N36S (p.Asn36Ser), ExAC rs752766475, TOPMed rs752766475, gnomAD rs752766475, REVEL 0.13, CADD 17.70, Uncertain significance
- N36T (p.Asn36Thr), rs752766475, ClinGen CA4205327, ClinVar RCV004105802, ExAC rs752766475, REVEL 0.17, CADD 23.80, Uncertain significance, not specified
- T37S (p.Thr37Ser), Ensembl rs2128069714
- C39R (p.Cys39Arg), 1000Genomes rs550336227, ExAC rs550336227, TOPMed rs550336227, gnomAD rs550336227, REVEL 0.57, CADD 27.00
- L40M (p.Leu40Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V41A (p.Val41Ala), ExAC rs760007889, TOPMed rs760007889, gnomAD rs760007889, REVEL 0.16, CADD 23.70
- V41L (p.Val41Leu), gnomAD rs1343595998
- N43S (p.Asn43Ser), TOPMed rs869218760
- D48V (p.Asp48Val), ExAC rs766821538, gnomAD rs766821538, REVEL 0.20, CADD 20.50
- Y49C (p.Tyr49Cys), ESP rs372023833, TOPMed rs372023833, gnomAD rs372023833, REVEL 0.25, CADD 27.00
- S51L (p.Ser51Leu), ExAC rs751690035, TOPMed rs751690035, gnomAD rs751690035, REVEL 0.24, CADD 23.30, Uncertain significance, not specified
- A52V (p.Ala52Val), rs1332709505, ClinGen CA367137203, NCI-TCGA Cosmic COSV5611, ClinVar RCV004266888, REVEL 0.06, CADD 2.44, Uncertain significance, not specified
- E53* (p.Glu53Ter), 1000Genomes rs150782149, ESP rs150782149, ExAC rs150782149, TOPMed rs150782149, CADD 36.00
- E53K (p.Glu53Lys), 1000Genomes rs150782149, ESP rs150782149, ExAC rs150782149, TOPMed rs150782149, REVEL 0.36, CADD 24.30
- E53V (p.Glu53Val), Ensembl rs1786420870
- D54E (p.Asp54Glu), Ensembl rs1786420081
- D54N (p.Asp54Asn), TOPMed rs1786420487, REVEL 0.35, CADD 22.80
- D54Y (p.Asp54Tyr), TOPMed rs1786420487
- A55S (p.Ala55Ser), TOPMed rs1243444671, gnomAD rs1243444671, REVEL 0.09, CADD 8.27, Uncertain significance
- A55T (p.Ala55Thr), rs1243444671, ClinGen CA367137152, ClinVar RCV004311056, TOPMed rs1243444671, REVEL 0.17, CADD 14.40, Uncertain significance, not specified
- A55V (p.Ala55Val), 1000Genomes rs6947097, ESP rs6947097, ExAC rs6947097, TOPMed rs6947097, REVEL 0.11, CADD 7.82
- E56D (p.Glu56Asp), TOPMed rs1407019652, gnomAD rs1407019652, REVEL 0.20, CADD 23.40
- I57V (p.Ile57Val), Ensembl rs2128069437
- C59* (p.Cys59Ter), TOPMed rs1157820719, gnomAD rs1157820719, CADD 35.00
- C61W (p.Cys61Trp), ExAC rs746747524, gnomAD rs746747524
- Q64* (p.Gln64Ter), ExAC rs777493139, gnomAD rs777493139, CADD 36.00
- Q64L (p.Gln64Leu), TOPMed rs1452098385
- P65A (p.Pro65Ala), TOPMed rs1170560196, gnomAD rs1170560196
- P65S (p.Pro65Ser), TOPMed rs1170560196, gnomAD rs1170560196, REVEL 0.12, CADD 14.40, Uncertain significance, not specified
- D66N (p.Asp66Asn), TOPMed rs1786414423, gnomAD rs1786414423, REVEL 0.18, CADD 21.50
- K67* (p.Lys67Ter), ExAC rs758603558, TOPMed rs758603558, gnomAD rs758603558, CADD 42.00
- K67E (p.Lys67Glu), ExAC rs758603558, TOPMed rs758603558, gnomAD rs758603558, REVEL 0.22, CADD 24.70
- K67N (p.Lys67Asn), ExAC rs752958736, TOPMed rs752958736, gnomAD rs752958736, REVEL 0.21, CADD 34.00
- V68I (p.Val68Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V68L (p.Val68Leu), gnomAD rs1330165648, REVEL 0.28, CADD 31.00
- R69C (p.Arg69Cys), rs201002349, ClinGen CA4205282, ClinVar RCV004200424, 1000Genomes rs201002349, REVEL 0.72, CADD 31.00, Uncertain significance, not specified
- R69H (p.Arg69His), rs768166122, ClinGen CA4205281, ClinVar RCV004197064, ExAC rs768166122, REVEL 0.65, CADD 28.00, Uncertain significance, not specified
- R69L (p.Arg69Leu), rs768166122, ExAC rs768166122, TOPMed rs768166122, gnomAD rs768166122, REVEL 0.69, CADD 27.50, Uncertain significance
- K70I (p.Lys70Ile), gnomAD rs1404752751, REVEL 0.28, CADD 25.30
- V75L (p.Val75Leu), ExAC rs762216677, gnomAD rs762216677, REVEL 0.11, CADD 24.90
- Q76H (p.Gln76His), NCI-TCGA Cosmic COSV5611, Variant assessed as somatic; moderate impact.
- Q76R (p.Gln76Arg), TOPMed rs898997209, REVEL 0.18, CADD 26.90
- S77G (p.Ser77Gly), Ensembl rs1376659755
- S77N (p.Ser77Asn), gnomAD rs1172651319, REVEL 0.19, CADD 23.60, Uncertain significance, not specified
- S77R (p.Ser77Arg), ExAC rs751982098, TOPMed rs751982098, gnomAD rs751982098, REVEL 0.18, CADD 23.90
- G79S (p.Gly79Ser), Ensembl rs1786231147
- E80K (p.Glu80Lys), ESP rs148120693, ExAC rs148120693, TOPMed rs148120693, gnomAD rs148120693, REVEL 0.19, CADD 26.90
- E81K (p.Glu81Lys), TOPMed rs1409101378, gnomAD rs1409101378, REVEL 0.20, CADD 24.30
- V82L (p.Val82Leu), rs770394928, ClinGen CA4205275, ClinVar RCV004344906, ExAC rs770394928, REVEL 0.16, CADD 19.00, Uncertain significance, not specified
- S83T (p.Ser83Thr), ExAC rs760265830, gnomAD rs760265830, REVEL 0.15, CADD 23.40
- E84K (p.Glu84Lys), ESP rs376537154, gnomAD rs376537154, REVEL 0.21, CADD 25.90
- E84Q (p.Glu84Gln), ESP rs376537154, gnomAD rs376537154, REVEL 0.25, CADD 23.60
- F85Y (p.Phe85Tyr), rs199475897, ClinGen CA230124, ClinVar RCV000089367, 1000Genomes rs199475897, REVEL 0.06, CADD 19.30, not provided
- L87F (p.Leu87Phe), ExAC rs778750751, gnomAD rs778750751, REVEL 0.07, CADD 22.70
- Y88C (p.Tyr88Cys), TOPMed rs780605529, gnomAD rs780605529, REVEL 0.06, CADD 21.10
- Y88F (p.Tyr88Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q91H (p.Gln91His), gnomAD rs1435507974, REVEL 0.07, CADD 17.00
- Q92E (p.Gln92Glu), ExAC rs749525016, gnomAD rs749525016, REVEL 0.06, CADD 14.10
- Q92H (p.Gln92His), NCI-TCGA Cosmic COSV9976, Variant assessed as somatic; moderate impact.
- Q92L (p.Gln92Leu), TOPMed rs1786224667
- L93F (p.Leu93Phe), TOPMed rs1235724392, gnomAD rs1235724392, REVEL 0.28, CADD 24.30
- A94T (p.Ala94Thr), ExAC rs756104363, TOPMed rs756104363, gnomAD rs756104363, REVEL 0.01, CADD 0.14
- A94V (p.Ala94Val), TOPMed rs1272907069, gnomAD rs1272907069, REVEL 0.05, CADD 3.81
- D95H (p.Asp95His), ExAC rs750535724, gnomAD rs750535724, REVEL 0.43, CADD 24.00
- A96S (p.Ala96Ser), TOPMed rs1206497788, gnomAD rs1206497788, REVEL 0.34, CADD 23.60
- A96V (p.Ala96Val), gnomAD rs902941750, REVEL 0.43, CADD 23.40
- Y97C (p.Tyr97Cys), NCI-TCGA TCGA novel, REVEL 0.32, CADD 24.70, Variant assessed as somatic; moderate impact.
- Y97N (p.Tyr97Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V98M (p.Val98Met), rs1422634724, gnomAD rs1422634724, REVEL 0.08, CADD 23.20, Variant assessed as somatic; moderate impact.
- D99N (p.Asp99Asn), ExAC rs757840023, gnomAD rs757840023, REVEL 0.20, CADD 22.40, Uncertain significance, not specified
- D99V (p.Asp99Val), 1000Genomes rs146084871, ESP rs146084871, ExAC rs146084871, TOPMed rs146084871, REVEL 0.60, CADD 26.60
- L100F (p.Leu100Phe), ExAC rs764609980, gnomAD rs764609980
- L100H (p.Leu100His), Ensembl rs773935994, REVEL 0.69, CADD 26.40
- P102H (p.Pro102His), 1000Genomes rs138824111, ESP rs138824111, ExAC rs138824111, TOPMed rs138824111, Uncertain significance
- P102L (p.Pro102Leu), rs138824111, ClinGen CA4205260, ClinVar RCV004487884, 1000Genomes rs138824111, REVEL 0.35, CADD 23.50, Uncertain significance, not specified
- P102T (p.Pro102Thr), ExAC rs759203398, gnomAD rs759203398, REVEL 0.58, CADD 25.20
- W103* (p.Trp103Ter), gnomAD rs1243887122, CADD 36.00
- L104R (p.Leu104Arg), ExAC rs766080418, TOPMed rs766080418, gnomAD rs766080418, REVEL 0.57, CADD 25.00
- E106G (p.Glu106Gly), TOPMed rs1786218368
- I107N (p.Ile107Asn), Ensembl rs1786217812
- G108C (p.Gly108Cys), gnomAD rs1278228905, REVEL 0.08, CADD 8.11
- G108S (p.Gly108Ser), gnomAD rs1278228905, REVEL 0.16, CADD 3.98
- S110F (p.Ser110Phe), ExAC rs761800408, REVEL 0.13, CADD 21.70
- P111S (p.Pro111Ser), NCI-TCGA Cosmic COSV5611, TOPMed rs1786215119, REVEL 0.15, CADD 18.60, Variant assessed as somatic; moderate impact.
- S112F (p.Ser112Phe), 1000Genomes rs145135608, ESP rs145135608, ExAC rs145135608, TOPMed rs145135608, REVEL 0.42, CADD 25.60
- L114F (p.Leu114Phe), ExAC rs780086681, gnomAD rs780086681, REVEL 0.13, CADD 18.20
- T115A (p.Thr115Ala), ExAC rs745864036, TOPMed rs745864036, gnomAD rs745864036, REVEL 0.05, CADD 13.30
- T115P (p.Thr115Pro), ExAC rs745864036, TOPMed rs745864036, gnomAD rs745864036, REVEL 0.05, CADD 18.10
- Q116H (p.Gln116His), TOPMed rs1434248554
- Q116L (p.Gln116Leu), ExAC rs781489015, gnomAD rs781489015, REVEL 0.05, CADD 7.23
- K118R (p.Lys118Arg), ESP rs138268329, gnomAD rs138268329, REVEL 0.01, CADD 9.27
- V119I (p.Val119Ile), Ensembl rs1786211850, REVEL 0.02, CADD 1.19
- V120L (p.Val120Leu), ExAC rs778249529, TOPMed rs778249529, gnomAD rs778249529, REVEL 0.13, CADD 19.80
- V120M (p.Val120Met), ExAC rs778249529, TOPMed rs778249529, gnomAD rs778249529, REVEL 0.23, CADD 23.10
- V121G (p.Val121Gly), ExAC rs758643711, gnomAD rs758643711, REVEL 0.30, CADD 25.40
- N122S (p.Asn122Ser), gnomAD rs879216683, REVEL 0.30, CADD 25.40
- N122T (p.Asn122Thr), gnomAD rs879216683, REVEL 0.36, CADD 26.00
- T123A (p.Thr123Ala), TOPMed rs1386416465, gnomAD rs1386416465
- T123I (p.Thr123Ile), TOPMed rs1184069820, gnomAD rs1184069820, REVEL 0.44, CADD 25.90
- T123N (p.Thr123Asn), TOPMed rs1184069820, gnomAD rs1184069820
- T123S (p.Thr123Ser), TOPMed rs1386416465, gnomAD rs1386416465, REVEL 0.20, CADD 24.90
- D124N (p.Asp124Asn), ExAC rs753119742, gnomAD rs753119742, REVEL 0.39, CADD 26.70
- P125A (p.Pro125Ala), ExAC rs755862567, gnomAD rs755862567, REVEL 0.43, CADD 23.40
- P125L (p.Pro125Leu), Ensembl rs908655824
- P125S (p.Pro125Ser), ExAC rs755862567, gnomAD rs755862567, REVEL 0.45, CADD 26.20, Uncertain significance, not specified
- V126=, NCI-TCGA Cosmic COSV5611, Variant assessed as somatic; low impact.
- V126L (p.Val126Leu), ExAC rs749926258, TOPMed rs749926258, gnomAD rs749926258, REVEL 0.18, CADD 33.00
- V126M (p.Val126Met), ExAC rs749926258, TOPMed rs749926258, gnomAD rs749926258, REVEL 0.19, CADD 33.00
- R128S (p.Arg128Ser), ExAC rs775134700, gnomAD rs775134700, REVEL 0.22, CADD 17.80
- Y129C (p.Tyr129Cys), ExAC rs765128426, gnomAD rs765128426, REVEL 0.73, CADD 27.40
- T130A (p.Thr130Ala), TOPMed rs1583775107, gnomAD rs1583775107, REVEL 0.03, CADD 16.50
- T130P (p.Thr130Pro), TOPMed rs1583775107, gnomAD rs1583775107
- Q131K (p.Gln131Lys), gnomAD rs1171930545, REVEL 0.06, CADD 18.10
- Q131R (p.Gln131Arg), Ensembl rs890540842
- Q132* (p.Gln132Ter), ExAC rs759798980, gnomAD rs759798980
- Q132K (p.Gln132Lys), rs759798980, ClinGen CA367135635, ClinVar RCV004178437, REVEL 0.13, CADD 14.70, Likely benign, not specified
- Q132R (p.Gln132Arg), TOPMed rs1785957187
- L133R (p.Leu133Arg), gnomAD rs1421513494, REVEL 0.70, CADD 26.20
- R134* (p.Arg134Ter), rs371807148, ESP rs371807148, ExAC rs371807148, TOPMed rs371807148, CADD 38.00, Variant assessed as somatic; high impact.
- R134Q (p.Arg134Gln), ExAC rs747020735, TOPMed rs747020735, gnomAD rs747020735, REVEL 0.09, CADD 21.70
- H136R (p.His136Arg), rs547986895, ClinGen CA4205210, ClinVar RCV004363675, ExAC rs547986895, REVEL 0.14, CADD 22.90, Uncertain significance, not specified
- H136Y (p.His136Tyr), TOPMed rs1454638584
- G138S (p.Gly138Ser), TOPMed rs1371276285, REVEL 0.18, CADD 22.10
- R139C (p.Arg139Cys), rs772446340, NCI-TCGA Cosmic COSV9976, ExAC rs772446340, TOPMed rs772446340, REVEL 0.07, CADD 13.60, Variant assessed as somatic; moderate impact.
- R139H (p.Arg139His), rs549088103, 1000Genomes rs549088103, ExAC rs549088103, TOPMed rs549088103, REVEL 0.19, CADD 15.80, Variant assessed as somatic; moderate impact.
- D140E (p.Asp140Glu), ExAC rs779120993, gnomAD rs779120993, REVEL 0.39, CADD 20.10
- D140G (p.Asp140Gly), NCI-TCGA Cosmic COSV9976, REVEL 0.66, CADD 26.30, Variant assessed as somatic; moderate impact.
- K142N (p.Lys142Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K142R (p.Lys142Arg), ExAC rs755297638, gnomAD rs755297638, REVEL 0.09, CADD 17.20
- F143L (p.Phe143Leu), ESP rs150469478, ExAC rs150469478, TOPMed rs150469478, gnomAD rs150469478, REVEL 0.46, CADD 24.90, Uncertain significance, not specified
- V144L (p.Val144Leu), rs201910425, ClinGen CA4205201, ClinVar RCV004487885, 1000Genomes rs201910425, REVEL 0.06, CADD 6.71, Uncertain significance, not specified
- V144M (p.Val144Met), 1000Genomes rs201910425, ESP rs201910425, ExAC rs201910425, TOPMed rs201910425, REVEL 0.09, CADD 11.40, Uncertain significance
- L145P (p.Leu145Pro), 1000Genomes rs140176390, ESP rs140176390, ExAC rs140176390, TOPMed rs140176390, REVEL 0.36, CADD 22.30
- C146Y (p.Cys146Tyr), gnomAD rs1244711059, REVEL 0.34, CADD 23.20
- Y147C (p.Tyr147Cys), ExAC rs753691409, TOPMed rs753691409, gnomAD rs753691409, REVEL 0.85, CADD 27.50
- Y147D (p.Tyr147Asp), ExAC rs759354279, TOPMed rs759354279, gnomAD rs759354279, REVEL 0.87, CADD 27.00, Uncertain significance, not specified
- Y147F (p.Tyr147Phe), ExAC rs753691409, TOPMed rs753691409, gnomAD rs753691409
- A148G (p.Ala148Gly), ExAC rs766706770, TOPMed rs766706770, gnomAD rs766706770, REVEL 0.12, CADD 8.45, Uncertain significance, not specified
- A148V (p.Ala148Val), ExAC rs766706770, TOPMed rs766706770, gnomAD rs766706770, REVEL 0.12, CADD 12.00
- E151D (p.Glu151Asp), ExAC rs761035608, gnomAD rs761035608, REVEL 0.38, CADD 23.80
- E151Q (p.Glu151Gln), TOPMed rs1039690583
Public NOD1 analysis runs
- NOD1 analysis run — NOD1 (1,315 variants) — completed 2026-08-22